by McKesson Ventures | Apr 25, 2024 | Portfolio News
Newsweek’s list of the World’s Best Digital Health Companies is a collaboration with Statista, and the inaugural rankings were released on April 25, 2024. The goal of the list is to inform potential patients and medical providers on which products, services, and data...
by McKesson Ventures | Apr 9, 2024 | Press Releases
On April 9, 2024, CancerIQ’s Founder and CEO Feyi Ayodele was named as one of Modern Healthcare’s Top Innovators of 2024. The list acknowledges innovators that are improving quality and access to care, as well as constantly striving to improve the clinical and...
by McKesson Ventures | Dec 7, 2023 | Press Releases
On Thursday, December 7, 2023, oncology and cancer-health screening company Cancer IQ announced a partnership with the Boston University School of Public Health to study racial and ethnic disparities in genetic counseling and testing for at-risk cancer patients. This...
by McKesson Ventures | Nov 26, 2023 | Press Releases
Densitas Inc, an artificial intelligence and technology company, announced on Sunday that it has partnered with the cancer prevention service CancerIQ to include Cancer IQ’s Tyrer-Cuzick Version 8 risk calculator in its breast cancer screening offerings. This 8th...
by McKesson Ventures | Oct 19, 2022 | Portfolio News
CancerIQ CEO and Founder Feyi Ayodele recently shared some ideas about how to bring equity to precision health. “We are living in an era of tremendous progress against cancer,” Ayodele writes. Tools such as immunotherapy and multicancer early detection tests have...
